327 related articles for article (PubMed ID: 18541796)
1. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin prolongs survival times in prion infections of the central nervous system.
Mok SW; Thelen KM; Riemer C; Bamme T; Gültner S; Lütjohann D; Baier M
Biochem Biophys Res Commun; 2006 Sep; 348(2):697-702. PubMed ID: 16890918
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
4. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
[TBL] [Abstract][Full Text] [Related]
5. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin treatment prolongs the survival of scrapie-infected mice.
Kempster S; Bate C; Williams A
Neuroreport; 2007 Mar; 18(5):479-82. PubMed ID: 17496807
[TBL] [Abstract][Full Text] [Related]
7. PrPSc level and incubation time in a transgenic mouse model expressing Borna disease virus phosphoprotein after intracerebral prion infection.
Sakudo A; Onodera T; Ikuta K
Neurosci Lett; 2008 Jan; 431(1):81-5. PubMed ID: 18155836
[TBL] [Abstract][Full Text] [Related]
8. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
9. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
10. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
11. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
12. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
13. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
Pimpinelli F; Lehmann S; Maridonneau-Parini I
Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
[TBL] [Abstract][Full Text] [Related]
14. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
16. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
17. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
18. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
19. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F
J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin enhances learning and memory independent of amyloid load in mice.
Li L; Cao D; Kim H; Lester R; Fukuchi K
Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]